603439 三力制药
已收盘 04-10 15:00:00
资讯
新帖
简况
每周股票复盘：三力制药（603439）受让16个药品上市许可
证券之星 · 04-05
每周股票复盘：三力制药（603439）受让16个药品上市许可
三力制药（603439）披露签署《药品上市许可持有人转让协议》，4月2日股价上涨0.09%
中金财经 · 04-02
三力制药（603439）披露签署《药品上市许可持有人转让协议》，4月2日股价上涨0.09%
三力制药最新公告：受让16个药品上市许可
证券之星 · 04-01
三力制药最新公告：受让16个药品上市许可
股市必读：三力制药（603439）3月23日收盘跌5.07%，主力净流出240.84万元
证券之星 · 03-24
股市必读：三力制药（603439）3月23日收盘跌5.07%，主力净流出240.84万元
每周股票复盘：三力制药（603439）回购40,000股限制性股票
证券之星 · 03-15
每周股票复盘：三力制药（603439）回购40,000股限制性股票
三力制药（603439）披露回购注销部分限制性股票公告，3月9日股价下跌0.42%
证券之星 · 03-09
三力制药（603439）披露回购注销部分限制性股票公告，3月9日股价下跌0.42%
股市必读：三力制药（603439）预计2025年全年归属净利润盈利3600万元至5200万元
证券之星 · 01-26
股市必读：三力制药（603439）预计2025年全年归属净利润盈利3600万元至5200万元
每周股票复盘：三力制药（603439）2025年净利预减81.02%至86.86%
证券之星 · 01-25
每周股票复盘：三力制药（603439）2025年净利预减81.02%至86.86%
三力制药（603439）披露2025年年度业绩预减公告，1月23日股价上涨0.82%
证券之星 · 01-23
三力制药（603439）披露2025年年度业绩预减公告，1月23日股价上涨0.82%
三力制药（603439）发布市值管理制度，12月25日股价上涨0.25%
证券之星 · 2025-12-25
三力制药（603439）发布市值管理制度，12月25日股价上涨0.25%
长护险将逐步覆盖所有参保人；减重版司美格鲁肽国内获批新适应证
21世纪经济报道 · 2025-12-23
长护险将逐步覆盖所有参保人；减重版司美格鲁肽国内获批新适应证
三力制药（603439）披露与海南大学签署技术转让合同，12月22日股价下跌0.25%
证券之星 · 2025-12-22
三力制药（603439）披露与海南大学签署技术转让合同，12月22日股价下跌0.25%
三力制药最新公告：拟受让海南大学HXW2324化合物及相关专利其用于开发阿尔茨海默病新型治疗药物的临床前候选化合物
证券之星 · 2025-12-22
三力制药最新公告：拟受让海南大学HXW2324化合物及相关专利其用于开发阿尔茨海默病新型治疗药物的临床前候选化合物
三力制药（603439）披露取消监事会并修订公司章程议案获通过，12月18日股价上涨0.85%
证券之星 · 2025-12-18
三力制药（603439）披露取消监事会并修订公司章程议案获通过，12月18日股价上涨0.85%
贵州三力：证券简称12日起变更为“三力制药”
每日经济新闻 · 2025-12-08
贵州三力：证券简称12日起变更为“三力制药”
贵州三力：公司的产品开喉剑喷雾剂（含儿童型）中药保护品种在申请中
证券日报 · 2025-12-03
贵州三力：公司的产品开喉剑喷雾剂（含儿童型）中药保护品种在申请中
贵州三力（603439）披露全资子公司退出与关联人共同投资企业暨关联交易终止，12月02日股价下跌0.66%
证券之星 · 2025-12-02
贵州三力（603439）披露全资子公司退出与关联人共同投资企业暨关联交易终止，12月02日股价下跌0.66%
贵州三力（603439）披露回购注销部分限制性股票公告，11月27日股价下跌0.33%
证券之星 · 2025-11-27
贵州三力（603439）披露回购注销部分限制性股票公告，11月27日股价下跌0.33%
贵州三力最新公告：拟变更公司证券简称为“三力制药”
证券之星 · 2025-11-27
贵州三力最新公告：拟变更公司证券简称为“三力制药”
每周股票复盘：贵州三力（603439）张海与悦欣医药签一致行动协议
证券之星 · 2025-11-09
每周股票复盘：贵州三力（603439）张海与悦欣医药签一致行动协议
加载更多
公司概况
公司名称：
贵州三力制药股份有限公司
所属行业：
医药制造业
上市日期：
2020-04-28
主营业务：
贵州三力制药股份有限公司的主营业务是药品的研发、生产及销售。公司的主要产品是开喉剑喷雾剂（儿童型）、开喉剑喷雾剂、芪胶升白胶囊、妇科再造丸、止嗽化痰丸、黄芪颗粒、强力天麻杜仲胶囊等。
发行价格：
7.35
{"stockData":{"symbol":"603439","market":"SH","secType":"STK","nameCN":"三力制药","latestPrice":11.04,"timestamp":1775804401000,"preClose":11.02,"halted":0,"volume":2110000,"delay":0,"changeRate":0.0018,"floatShares":404000000,"shares":409000000,"eps":0.393,"marketStatus":"已收盘","change":0.02,"latestTime":"04-10 15:00:00","open":11.04,"high":11.17,"low":11.01,"amount":23397500,"amplitude":0.0145,"askPrice":11.04,"askSize":15,"bidPrice":11.03,"bidSize":148,"shortable":0,"etf":0,"ttmEps":0.393,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1776043800000},"marketStatusCode":5,"adr":0,"adjPreClose":11.02,"symbolType":"stock","openAndCloseTimeList":[[1775784600000,1775791800000],[1775797200000,1775804400000]],"highLimit":12.12,"lowLimit":9.92,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":408930216,"isCdr":false,"pbRate":3.05,"roa":"--","peRate":28.091603,"roe":"5.37%","epsLYR":0.67,"committee":0.624204,"marketValue":4515000000,"turnoverRate":0.0052,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-04-13。","floatMarketCap":4458000000},"requestUrl":"/m/hq/s/603439","defaultTab":"news","newsList":[{"id":"2625361160","title":"每周股票复盘：三力制药（603439）受让16个药品上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2625361160","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625361160?lang=zh_cn&edition=full","pubTime":"2026-04-05 04:07","pubTimestamp":1775333230,"startTime":"0","endTime":"0","summary":"截至2026年4月3日收盘，三力制药报收于11.06元，较上周的11.04元上涨0.18%。本周，三力制药4月2日盘中最高价报11.49元。三力制药当前最新总市值45.23亿元，在中药板块市值排名44/67，在两市A股市值排名3543/5193。本周关注点公司公告汇总：三力制药受让顺铂氯化钠注射液等16个药品上市许可，转让价款200万元。其中顺铂氯化钠注射液为核心品种，其余15个品种在核心品种转让完成后无偿赠予公司。药品上市许可变更尚需监管部门审批，存在不确定性。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040500001289.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624757744","title":"三力制药（603439）披露签署《药品上市许可持有人转让协议》，4月2日股价上涨0.09%","url":"https://stock-news.laohu8.com/highlight/detail?id=2624757744","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624757744?lang=zh_cn&edition=full","pubTime":"2026-04-02 17:54","pubTimestamp":1775123693,"startTime":"0","endTime":"0","summary":"公司于近日披露《贵州三力制药股份有限公司关于签署〈药品上市许可持有人转让协议〉的公告》。公告显示，三力制药与贵州汉方制药有限公司签署协议，受让顺铂氯化钠注射液等16个药品的上市许可及相关权益，转让价款(含税)为人民币200万元。其中顺铂氯化钠注射液为核心品种，其余15个品种在核心品种转让完成后无偿赠予公司。药品上市许可变更尚需监管部门审批，存在不确定性。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushiyaowen/20260402/32121738.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624591622","title":"三力制药最新公告：受让16个药品上市许可","url":"https://stock-news.laohu8.com/highlight/detail?id=2624591622","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624591622?lang=zh_cn&edition=full","pubTime":"2026-04-01 17:39","pubTimestamp":1775036380,"startTime":"0","endTime":"0","summary":"三力制药(603439.SH)公告称，公司与贵州汉方制药有限公司签署《药品上市许可持有人转让协议》，汉方制药将其持有的顺铂氯化钠注射液等16个药品上市许可及相关权益转让给公司，其中顺铂氯化钠注射液为核心品种。本次交易转让价款(含税)为200万元，除核心品种外其余15个品种无偿赠予。本次交易不构成关联交易及重大资产重组，无需提交董事会审议。目前药品上市许可持有人变更尚需监管部门审批，能否顺利完成存在不确定性。该事项对公司当期业绩不构成重大影响。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040100032375.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621084869","title":"股市必读：三力制药（603439）3月23日收盘跌5.07%，主力净流出240.84万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621084869","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621084869?lang=zh_cn&edition=full","pubTime":"2026-03-24 04:11","pubTimestamp":1774296671,"startTime":"0","endTime":"0","summary":"截至2026年3月23日收盘，三力制药报收于10.49元，下跌5.07%，换手率1.0%，成交量4.05万手，成交额4317.53万元。交易信息汇总股价提醒3月23日三力制药收盘报10.49元，跌5.07%，当日成交404.9万元。根据收盘数据统计，该股已连续5日下跌。资金流向3月23日主力资金净流出240.84万元，占总成交额5.58%；游资资金净流出202.6万元，占总成交额4.69%；散户资金净流入443.44万元，占总成交额10.27%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032400004729.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619376178","title":"每周股票复盘：三力制药（603439）回购40,000股限制性股票","url":"https://stock-news.laohu8.com/highlight/detail?id=2619376178","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619376178?lang=zh_cn&edition=full","pubTime":"2026-03-15 02:45","pubTimestamp":1773513914,"startTime":"0","endTime":"0","summary":"截至2026年3月13日收盘，三力制药报收于11.65元，较上周的11.78元下跌1.1%。本周，三力制药3月10日盘中最高价报11.82元。本周关注点公司公告汇总：因激励对象冯由超离职，三力制药拟回购注销其未解锁的40,000股限制性股票。公司公告汇总：回购注销后公司总股本将由408,930,216股变更为408,690,216股。公司公告汇总贵州三力制药股份有限公司于2026年3月9日召开第四届董事会第二十二次会议，审议通过《关于回购注销部分限制性股票的议案》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031500000771.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618627120","title":"三力制药（603439）披露回购注销部分限制性股票公告，3月9日股价下跌0.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2618627120","media":"证券之星","labels":["buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2618627120?lang=zh_cn&edition=full","pubTime":"2026-03-09 22:56","pubTimestamp":1773068176,"startTime":"0","endTime":"0","summary":"截至2026年3月9日收盘，三力制药报收于11.73元，较前一交易日下跌0.42%，最新总市值为47.97亿元。该股当日开盘11.63元，最高11.75元，最低11.59元，成交额达2019.49万元，换手率为0.43%。贵州三力制药股份有限公司于2026年3月9日召开第四届董事会第二十二次会议，审议通过《关于回购注销部分限制性股票的议案》。本次回购注销不影响公司股权激励计划的继续实施，不会对公司的财务状况和经营成果产生实质性影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030900035700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606265950","title":"股市必读：三力制药（603439）预计2025年全年归属净利润盈利3600万元至5200万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2606265950","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606265950?lang=zh_cn&edition=full","pubTime":"2026-01-26 03:18","pubTimestamp":1769368694,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，三力制药报收于12.3元，上涨0.82%，换手率1.19%，成交量4.81万手，成交额5912.22万元。来自公司公告汇总：三力制药预计2025年扣非后净利润同比减少87.31%到91.42%，主要受中成药行业增长放缓及子公司商誉减值影响。三力制药发布业绩预告，预计2025年全年扣非后净利润盈利2300万元至3400万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012600001467.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606232089","title":"每周股票复盘：三力制药（603439）2025年净利预减81.02%至86.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2606232089","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606232089?lang=zh_cn&edition=full","pubTime":"2026-01-25 03:15","pubTimestamp":1769282113,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，三力制药报收于12.3元，较上周的11.88元上涨3.54%。来自公司公告汇总：三力制药预计2025年净利同比减少81.02%至86.86%，主因商誉减值约1.3亿元。三力制药发布业绩预告，预计2025年全年归属净利润盈利3600万元至5200万元。公司公告汇总贵州三力制药股份有限公司预计2025年年度归属于母公司所有者的净利润为3,600.00万元到5,200.00万元，同比减少81.02%到86.86%；扣除非经常性损益后的净利润为2,300.00万元到3,400.00万元，同比减少87.31%到91.42%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012500001129.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605409936","title":"三力制药（603439）披露2025年年度业绩预减公告，1月23日股价上涨0.82%","url":"https://stock-news.laohu8.com/highlight/detail?id=2605409936","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605409936?lang=zh_cn&edition=full","pubTime":"2026-01-23 23:04","pubTimestamp":1769180664,"startTime":"0","endTime":"0","summary":"截至2026年1月23日收盘，三力制药报收于12.3元，较前一交易日上涨0.82%，最新总市值为50.3亿元。该股当日开盘12.2元，最高12.43元，最低12.19元，成交额达5912.22万元，换手率为1.19%。近日，贵州三力制药股份有限公司发布《2025年年度业绩预减公告》。公告显示，公司预计2025年年度归属于母公司所有者的净利润为3,600.00万元到5,200.00万元，同比减少81.02%到86.86%；扣除非经常性损益后的净利润为2,300.00万元到3,400.00万元，同比减少87.31%到91.42%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300043661.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594237014","title":"三力制药（603439）发布市值管理制度，12月25日股价上涨0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2594237014","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594237014?lang=zh_cn&edition=full","pubTime":"2025-12-25 22:50","pubTimestamp":1766674233,"startTime":"0","endTime":"0","summary":"截至2025年12月25日收盘，三力制药报收于11.87元，较前一交易日上涨0.25%，最新总市值为48.54亿元。该股当日开盘11.81元，最高11.88元，最低11.81元，成交额达1917.18万元，换手率为0.4%。近日，贵州三力制药股份有限公司发布公告，制定《市值管理制度》。公司可综合运用并购重组、股权激励、现金分红、投资者关系管理、信息披露、股份回购等方式开展市值管理，并建立监测预警机制，应对股价异常波动。公告同时强调，严禁内幕交易、操纵市场等违法违规行为。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500036426.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593645198","title":"长护险将逐步覆盖所有参保人；减重版司美格鲁肽国内获批新适应证","url":"https://stock-news.laohu8.com/highlight/detail?id=2593645198","media":"21世纪经济报道","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593645198?lang=zh_cn&edition=full","pubTime":"2025-12-23 08:10","pubTimestamp":1766448612,"startTime":"0","endTime":"0","summary":"政策动向国家医保局：“十五五”时期长期护理保险制度将从试点转向全面建制12月22日，在2025全国长期护理保险高质量发展大会上，国家医保局党组书记、局长章轲在致辞时表示，经过试点，长期护理保险制度覆盖近3亿人，累计惠及超330万失能群众，基金支出超千亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512233598873113.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512233598873113.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU1226287529.USD","LU0501845795.SGD","LU1951186391.HKD","IE00B031HY20.USD","IE0008368742.USD","LU0140636845.USD","BK1521","BK0239","IE00BZ08YT58.USD","LU0072913022.USD","IE00B5MMRT66.SGD","BK1191","IE00BZ08YS42.EUR","LU1226288253.USD","LU1328277881.USD","603439","IE00B543WZ88.USD","BK0092","LU1807302812.USD","LU1960683339.HKD","BK0046","01093","LU2039709279.SGD","LU1813983027.USD","LU1152091168.USD","LU1008478684.HKD","LU1993786604.SGD","SG9999004220.SGD","IE0008369823.USD","002873","HK0000165453.HKD","LU1152091754.HKD","PCT","IE00BZ08YR35.GBP","LU0315179316.USD","LU0314109678.HKD","LU0326950275.SGD","LU0880133367.SGD","688580","BK0213","LU1226288170.HKD","LU1226287875.USD","BK1515","002086","BK4090","LU0067412154.USD","BK0251","LU1226287792.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593435602","title":"三力制药（603439）披露与海南大学签署技术转让合同，12月22日股价下跌0.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593435602","media":"证券之星","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593435602?lang=zh_cn&edition=full","pubTime":"2025-12-22 22:46","pubTimestamp":1766414815,"startTime":"0","endTime":"0","summary":"截至2025年12月22日收盘，三力制药报收于11.82元，较前一交易日下跌0.25%，最新总市值为48.34亿元。该股当日开盘11.81元，最高11.88元，最低11.8元，成交额达2543.71万元，换手率为0.53%。近日，贵州三力制药股份有限公司发布公告称，公司与海南大学签署《技术转让合同》，受让HXW2324化合物及相关专利申请权，该化合物为阿尔茨海默病新型治疗药物的临床前候选化合物。转让价款总额2亿元，包含里程碑款和销售提成。公司已于2025年12月22日召开董事会审议通过该事项。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200035411.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593485529","title":"三力制药最新公告：拟受让海南大学HXW2324化合物及相关专利其用于开发阿尔茨海默病新型治疗药物的临床前候选化合物","url":"https://stock-news.laohu8.com/highlight/detail?id=2593485529","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593485529?lang=zh_cn&edition=full","pubTime":"2025-12-22 17:43","pubTimestamp":1766396609,"startTime":"0","endTime":"0","summary":"三力制药(603439.SH)公告称，公司与海南大学签署了《技术转让（专利申请权）合同》，旨在通过整合公司产业化能力与高校研发资源，推动创新药物科研成果转化。合同约定海南大学将其HXW2324化合物及相关专利的专利申请权转让给三力制药，转让价款总额为2亿元，包括里程碑款0.2亿元和销售提成1.8亿元。HXW2324化合物是用于开发阿尔茨海默病(Alzheimer'sdisease,AD)新型治疗药物的临床前候选化合物。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122200021989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2592990261","title":"三力制药（603439）披露取消监事会并修订公司章程议案获通过，12月18日股价上涨0.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2592990261","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2592990261?lang=zh_cn&edition=full","pubTime":"2025-12-18 22:37","pubTimestamp":1766068637,"startTime":"0","endTime":"0","summary":"截至2025年12月18日收盘，三力制药报收于11.8元，较前一交易日上涨0.85%，最新总市值为48.25亿元。该股当日开盘11.6元，最高11.9元，最低11.6元，成交额达2810.14万元，换手率为0.59%。所有议案均获得通过，其中特别表决议案已获出席股东所持表决权三分之二以上通过。北京市中伦律师事务所对本次会议出具法律意见书，确认会议召集、召开程序及表决结果合法有效。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025121800039189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2589332575","title":"贵州三力：证券简称12日起变更为“三力制药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2589332575","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2589332575?lang=zh_cn&edition=full","pubTime":"2025-12-08 18:56","pubTimestamp":1765191360,"startTime":"0","endTime":"0","summary":"每经AI快讯，12月8日，贵州三力公告，公司证券简称将于12月12日起由“贵州三力”变更为“三力制药”，公司证券代码“603439”保持不变。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2025-12-08/doc-inhaavvc2311126.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2025-12-08/doc-inhaavvc2311126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","BK1574","603439","161027","01477","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588044964","title":"贵州三力：公司的产品开喉剑喷雾剂（含儿童型）中药保护品种在申请中","url":"https://stock-news.laohu8.com/highlight/detail?id=2588044964","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588044964?lang=zh_cn&edition=full","pubTime":"2025-12-03 21:37","pubTimestamp":1764769020,"startTime":"0","endTime":"0","summary":"证券日报网讯 12月3日，贵州三力在互动平台回答投资者提问时表示，公司的产品开喉剑喷雾剂（含儿童型）中药保护品种在申请中。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-03/doc-infzpwtu1061929.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-03/doc-infzpwtu1061929.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","603439"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2588513600","title":"贵州三力（603439）披露全资子公司退出与关联人共同投资企业暨关联交易终止，12月02日股价下跌0.66%","url":"https://stock-news.laohu8.com/highlight/detail?id=2588513600","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2588513600?lang=zh_cn&edition=full","pubTime":"2025-12-02 22:31","pubTimestamp":1764685919,"startTime":"0","endTime":"0","summary":"截至2025年12月2日收盘，贵州三力报收于12.01元，较前一交易日下跌0.66%，最新总市值为49.11亿元。该股当日开盘12.08元，最高12.09元，最低11.95元，成交额达2895.7万元，换手率为0.6%。近日，贵州三力制药股份有限公司发布公告称，其全资子公司贵州三力健康管理有限公司拟退出与关联方共同投资的企业药尊宝数智科技（成都市）有限公司。三力健康原认缴出资2,000万元，持股25%，未实缴。本次减资不涉及价款支付。本次交易不会对公司财务及经营状况造成重大影响。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025120200040102.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586022515","title":"贵州三力（603439）披露回购注销部分限制性股票公告，11月27日股价下跌0.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2586022515","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586022515?lang=zh_cn&edition=full","pubTime":"2025-11-27 22:27","pubTimestamp":1764253640,"startTime":"0","endTime":"0","summary":"截至2025年11月27日收盘，贵州三力报收于11.96元，较前一交易日下跌0.33%，最新总市值为48.91亿元。该股当日开盘11.98元，最高12.05元，最低11.91元，成交额达3573.84万元，换手率为0.74%。近日，贵州三力制药股份有限公司发布公告称，公司于2025年11月27日召开董事会及监事会会议，审议通过《关于回购注销部分限制性股票的议案》。本次回购注销不影响公司股权激励计划的继续实施，不会对公司的财务状况和经营成果产生实质性影响。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700038606.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603439","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2586824132","title":"贵州三力最新公告：拟变更公司证券简称为“三力制药”","url":"https://stock-news.laohu8.com/highlight/detail?id=2586824132","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586824132?lang=zh_cn&edition=full","pubTime":"2025-11-27 18:19","pubTimestamp":1764238788,"startTime":"0","endTime":"0","summary":"贵州三力(603439.SH)公告称，公司于2025年11月27日召开董事会，审议通过将证券简称由“贵州三力”变更为“三力制药”，公司全称和证券代码保持不变。本次变更证券简称旨在使证券简称更清晰反映公司主营业务，强化企业品牌形象。变更后的证券简称与公司主营业务和战略规划相匹配，符合相关法律法规。该事项尚需向上海证券交易所申请，并经上海证券交易所办理后方可实施。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112700027802.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1191","BK0239","BK1574","01477","603439","161027"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582864972","title":"每周股票复盘：贵州三力（603439）张海与悦欣医药签一致行动协议","url":"https://stock-news.laohu8.com/highlight/detail?id=2582864972","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582864972?lang=zh_cn&edition=full","pubTime":"2025-11-09 05:11","pubTimestamp":1762636274,"startTime":"0","endTime":"0","summary":"本周关注点公司公告汇总：张海与悦欣医药签署一致行动协议，合计持股比例升至48.68%。公司公告汇总贵州三力制药股份有限公司信息披露义务人张海与海南悦欣医药投资合伙企业签署《一致行动协议》，导致合计持有公司股份比例由43.74%上升至48.68%。贵州三力制药股份有限公司控股股东张海与股东悦欣医药签署《一致行动协议》，协议有效期12个月。王惠英为张海母亲，已纳入一致行动人范围。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110900001860.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1161","159938","BK1515","BK0239","BK1574","603439","09939"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1775921805147,"stockEarnings":[{"period":"1week","weight":-0.0018},{"period":"1month","weight":-0.0556},{"period":"3month","weight":-0.0707},{"period":"6month","weight":-0.1238},{"period":"1year","weight":-0.0986},{"period":"ytd","weight":-0.0564}],"compareEarnings":[{"period":"1week","weight":0.0274},{"period":"1month","weight":-0.0356},{"period":"3month","weight":-0.0326},{"period":"6month","weight":0.0229},{"period":"1year","weight":0.2366},{"period":"ytd","weight":0.0044}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"贵州三力制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"26336人(较上一季度增加1.99%)","perCapita":"15334股","listingDate":"2020-04-28","address":"贵州省安顺市平坝区夏云工业园区","registeredCapital":"40893万元","survey":" 贵州三力制药股份有限公司的主营业务是药品的研发、生产及销售。公司的主要产品是开喉剑喷雾剂（儿童型）、开喉剑喷雾剂、芪胶升白胶囊、妇科再造丸、止嗽化痰丸、黄芪颗粒、强力天麻杜仲胶囊等。","listedPrice":7.35},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"三力制药(603439)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供三力制药(603439)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"三力制药,603439,三力制药股票,三力制药股票老虎,三力制药股票老虎国际,三力制药行情,三力制药股票行情,三力制药股价,三力制药股市,三力制药股票价格,三力制药股票交易,三力制药股票购买,三力制药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"三力制药(603439)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供三力制药(603439)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}